Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173542 | SCV000224664 | uncertain significance | not provided | 2015-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852111 | SCV002160708 | uncertain significance | Combined immunodeficiency due to ORAI1 deficiency; Myopathy, tubular aggregate, 2 | 2024-11-24 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the ORAI1 mRNA. The next in-frame methionine is located at codon 64. This variant is present in population databases (rs797044624, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with ORAI1-related conditions. ClinVar contains an entry for this variant (Variation ID: 193470). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001852111 | SCV002779331 | uncertain significance | Combined immunodeficiency due to ORAI1 deficiency; Myopathy, tubular aggregate, 2 | 2022-05-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000173542 | SCV004235682 | uncertain significance | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing |